These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2572424)

  • 1. The enantiomers of the dopamine agonist N-0437: in vivo and in vitro effects on the release of striatal dopamine.
    Timmerman W; Dubocovich ML; Westerink BH; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1989 Jul; 166(1):1-11. PubMed ID: 2572424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437.
    Timmerman W; Westerink BH; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1989 Mar; 162(1):143-50. PubMed ID: 2566492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis.
    Timmerman W; Tepper PG; Dijkstra D; Stoelwinder H; Grol CJ; Westerink BH; Horn AS
    Eur J Pharmacol; 1991 Jun; 199(2):145-51. PubMed ID: 1683287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of D-2 agonists on the release of dopamine: localization of the mechanism of action.
    Timmerman W; De Vries JB; Westerink BH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):650-4. PubMed ID: 1982893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of the enantiomers of the dopamine agonist N-0437 on food consumption and yawning behaviour in rats.
    Timmerman W; Rusk IN; Tepper P; Horn AS; Cooper SJ
    Eur J Pharmacol; 1989 Dec; 174(1):107-14. PubMed ID: 2575532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
    Santiago M; Westerink BH
    J Neurochem; 1991 Sep; 57(3):738-47. PubMed ID: 1677674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further in vitro and in vivo studies with the putative presynaptic dopamine agonist N,N-dipropyl-7-hydroxy-2-aminotetralin.
    Mulder TB; de Vries JB; Dijkstra D; Wiechers JW; Grol CJ; Horn AS
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):494-501. PubMed ID: 2830544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J; De Vries JB; Tepper PG; Krause DN; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Mar; 147(2):249-58. PubMed ID: 3130270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum.
    Tanaka T; Vincent SR; Nomikos GG; Fibiger HC
    J Neurochem; 1992 Nov; 59(5):1640-5. PubMed ID: 1357098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW; Abercrombie ED
    J Neurochem; 1999 Apr; 72(4):1516-22. PubMed ID: 10098856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evidence for the existence of autoreceptors on dopaminergic, serotonergic, and cholinergic neurons in the brain.
    Westerink BH; De Boer P; Timmerman W; De Vries JB
    Ann N Y Acad Sci; 1990; 604():492-504. PubMed ID: 1977359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of kainic acid and 6-hydroxydopamine lesions, metal ions and GTP on in vitro binding of the D-2 dopamine agonist, [3H]N-0437, to striatal membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Nov; 143(1):101-7. PubMed ID: 3121365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential antipsychotic activity of the partial dopamine receptor agonist (+)N-0437.
    Timmerman W; Tepper PG; Bohus BG; Horn AS
    Eur J Pharmacol; 1990 Jun; 181(3):253-60. PubMed ID: 1974516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of striatal dopamine release by the selective D-2 dopamine receptor agonist N-0437 is blocked by quinine.
    Cass WA; Zahniser NR
    Synapse; 1990; 5(4):336-7. PubMed ID: 2141733
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous dopamine release from rat striatal slices and its regulation by D-2 autoreceptors: effects of uptake inhibitors and synthesis inhibition.
    Herdon H; Strupish J; Nahorski SR
    Eur J Pharmacol; 1987 Jun; 138(1):69-76. PubMed ID: 3622608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis.
    de Boer P; Damsma G; Fibiger HC; Timmerman W; de Vries JB; Westerink BH
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):528-34. PubMed ID: 2090951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.